Physician

Internal Medicine

Christopher Recknor is an expert in the field of Internal Medicine. He went to Medical University of South Carolina. Christopher Recknor is also published. He has 25 publications published. The lastest publication: "Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.'

Publications

---

• Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial.
• The Effect of Discontinuing Treatment with Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women with Low Bone Mineral Density.
• Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study.
• Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who rem...
• Discontinuation of denosumab and associated fracture incidence: analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) t...
• Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture.
• Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial.
• Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures.
• Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass.
• Zoledronic acid for prevention and treatment of osteoporosis.
• Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON-Recurrent Fracture Trial.
• Zoledronic acid and clinical fractures and mortality after hip fracture.
• Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT.
• Zoledronic acid for the prevention of bone loss in postmenopausal women with low bone mass: a randomized controlled trial.
• Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive ag...
• Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal f...
• Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
• Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Iba...
• Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture.
• Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate.
• Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
• Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.
• A Longitudinal Study of Skeletal Histomorphometry at 6 and 24 Months Across Four Bone Envelopes in Postmenopausal Women with Osteoporosis Receiving Teriparatide or Zol...
• Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.

Schools

---

• Medical University of South Carolina

• Med University Sc College Of Med

Doctors Specialties

---

• Internal Medicine

Accepted Insurances

---

• Aetna HMO
• Choice Plus POS II
• American Republic
• Blue Card PPO
• CHAMPVA
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• Open Access Plus
• Commercial Insurance Company
• Coventry Health Care
• First Health (Coventry Health Care) PPO
• Golden Rule
• Harvard Pilgrim Health Care PPO
• HealthSmart
• Choice Care PPO
• Kaiser Permanente
• Medical Mutual of Ohio
• Medicare MCR
• Medico
• MultiPlan PPO
• PHCS Network PPO
• Mutual of Omaha
• POMCO Group
• Choice Plus POS
• Navigate HMO
• Navigate POS
• Options PPO
• United Healthcare

Education

---

• Medical University of South Carolina
• Medical University of South Carolina College of Medicine

Hospital

---

• Northeast Georgia Medical Center

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Nitya Reddy, MD This Doctor is OpenDoctor Recommended.
	Dr. Bradley H. Pierce, MD This Doctor is OpenDoctor Recommended.
	Dr. Eileen D. Javellana, MD This Doctor is OpenDoctor Recommended.
	Dr. Brent J. Archer, MD This Doctor is OpenDoctor Recommended.
	Dr. Eric A. Marsh, MD
	Dr. Kenneth W. Fogarty II, MD This Doctor is OpenDoctor Recommended.
	Dr. Rashi Gambhir, MD This Doctor is OpenDoctor Recommended.
	Dr. Paul H. Chenard, MD This Doctor is OpenDoctor Recommended.
	Dr. Roger D. Owens, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert P. Marler, MD This Doctor is OpenDoctor Recommended.
	Dr. Margaret A. Davis, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Charles N. Kelley, MD
	Dr. Linwood W. Zoller III, MD This Doctor is OpenDoctor Recommended.
	Dr. C S. Bussler, MD
	Dr. Sharif F. Elkabbani, MD This Doctor is OpenDoctor Recommended.
	Dr. Kenil J. Sidhpura, MD This Doctor is OpenDoctor Recommended.
	Olha Azad

---

Doctor Directory | TOS | twitter | FB | Angel | blog